A Pilot Phase II Two-Arm, Randomized Clinical Trial of Concomitant Immunotherapy (With Interferon-Alpha and Retinoic Acid) and Radiation Therapy for the Treatment of Advanced Cervical Cancer in India.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interferon alpha-2b (Primary) ; Isotretinoin (Primary) ; Cisplatin
- Indications Cervical cancer; Human papillomavirus infections
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 29 Dec 2017 Biomarkers information updated
- 14 May 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 14 May 2013 Planned end date changed from 1 Oct 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.